Align Technology, Inc.
ALGN
Classifica tra le azioni
#1981
Align Technology, Inc. is a medical technology enterprise that develops,... Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
Prezzo delle azioni
$148.95
Capitalizzazione di mercato
$10.58B
Variazione (1 giorno)
-0.03%
Variazione (1 anno)
10.39%
Paese
US
Scambia Align Technology, Inc. (ALGN)
Categoria
Healthcare
Rapporto P/E per Align Technology, Inc. (ALGN)
Rapporto P/E al October 2026 TTM: 25.08
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Align Technology, Inc., il rapporto P/E attuale (TTM) è 25.08. Alla fine del 2024, il rapporto P/E era 37.05.
Storico del rapporto P/E per Align Technology, Inc. da 2000 a 2026
Rapporto P/E alla fine di ogni anno
| Anno | Rapporto P/E | Cambia |
|---|---|---|
| 2026 (TTM) | 25.08 | -9.14% |
| 2025 | 27.60 | -25.50% |
| 2024 | 37.05 | -21.25% |
| 2023 | 47.05 | 3.17% |
| 2022 | 45.61 | -32.11% |
| 2021 | 67.18 | 183.46% |
| 2020 | 23.70 | -52.65% |
| 2019 | 50.05 | 19.47% |
| 2018 | 41.89 | -45.51% |
| 2017 | 76.89 | 89.99% |
| 2016 | 40.47 | 10.64% |
| 2015 | 36.58 | 18.14% |
| 2014 | 30.96 | -56.75% |
| 2013 | 71.59 | 88.02% |
| 2012 | 38.07 | 37.29% |
| 2011 | 27.73 | 38.99% |
| 2010 | 19.95 | -150.67% |
| 2009 | -39.38 | -638.75% |
| 2008 | 7.31 | -76.70% |
| 2007 | 31.37 | -224.12% |
| 2006 | -25.27 | -108.95% |
| 2005 | 282.26 | 283.94% |
| 2004 | 73.52 | -255.13% |
| 2003 | -47.39 | 2,511.46% |
| 2002 | -1.81 | -5.45% |
| 2001 | -1.92 | 81.95% |
| 2000 | -1.05 | 0.00% |
Rapporto P/E per aziende simili o concorrenti
| Azienda | P/E Ratio | Differenza del P/E Ratio | Il paese |
|---|---|---|---|
| 33.11 | 32.03% |
US
|
|
| 21.39 | -14.71% |
IE
|
|
| 28.94 | 15.43% |
US
|
|
| 17.34 | -30.86% |
US
|
|
| - | - |
DE
|
Come leggere un P/E ratio?
Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.
Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.
Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.